NeoSCOPE RTTQA: pre-accrual and on-trial review of all patients in a UK oesophageal RT trial

NeoSCOPE RTTQA: pre-accrual and on-trial review of all patients in a UK oesophageal RT trial

RTTQA is required to ensure adherence to the outlining and planning aspects of the trial protocol as variations can lead to poorer outcomes. NeoSCOPE, a UK phase II randomized control trial of two neoadjuvant chemoradiotherapy regimens in oesophageal cancer, undertook a comprehensive RTTQA programme...

Full description

Bibliographic Details
Main Authors:	Evans, E, Jones, G, Rackley, T, Maggs, R, Radhakrishna, G, Mukherjee, S, Hawkins, M, Crosby, T, Gwynne, S
Format:	Conference item
Published:	Elsevier 2018

Similar Items

4DCT oesophageal tumour delineation in SCOPE2 – how is radiotherapy quality assurance beneficial?
by: Cox, S, et al.
Published: (2018)

The influence of dose distribution on treatment outcome in the SCOPE 1 oesophageal cancer trial
by: Carrington, E, et al.
Published: (2016)

NEOSCOPE: a randomised Phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine or paclitaxel/carboplatin based chemoradiation as pre-operative regimen for resectable oesophageal adenocarcinoma.
by: Mukherjee, S, et al.
Published: (2015)

NEOSCOPE: a randomised Phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine or paclitaxel/carboplatin based chemoradiation as pre-operative regimen for resectable oesophageal adenocarcinoma.
by: Mukherjee, S, et al.
Published: (2015)

NEOSCOPE: A randomised phase II study of induction chemotherapy followed by oxaliplatin/capecitabine or carboplatin/paclitaxel based pre-operative chemoradiation for resectable oesophageal adenocarcinoma
by: Mukherjee, S, et al.
Published: (2017)

Oesophageal Chemoradiotherapy in the UK-Current Practice and Future Directions
by: Gwynne, S, et al.
Published: (2013)

Oesophageal Chemoradiotherapy in the UK--current practice and future directions.
by: Gwynne, S, et al.
Published: (2013)

Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2/3 randomised trial.
by: Crosby, T, et al.
Published: (2013)

Improving radiotherapy quality assurance in clinical trials: assessment of target volume delineation of the pre-accrual benchmark case.
by: Gwynne, S, et al.
Published: (2013)

Long-term results and recurrence patterns from SCOPE-1: a phase II/III randomised trial of definitive chemoradiotherapy +/− cetuximab in oesophageal cancer
by: Crosby, T, et al.
Published: (2017)

Differential clonal evolution in oesophageal cancers in response to neo-adjuvant chemotherapy
by: Findlay, J, et al.
Published: (2016)

The effect of dose escalation on gastric toxicity when treating lower oesophageal tumours: A radiobiological investigation
by: Carrington, R, et al.
Published: (2015)

Can protons reduce bone marrow toxicity in definitive chemoradiotherapy for oesophageal tumours?
by: Warren, S, et al.
Published: (2016)

Adjuvant radiotherapy following neo-adjuvant chemotherapy and surgery in oesophageal cancer: a retrospective cohort study of survival
by: Teoh, S, et al.
Published: (2018)

Small cell oesophageal carcinoma: an institutional experience and review of the literature.
by: Hudson, E, et al.
Published: (2007)

Optimising RT dose for anal cancer - the development of three clinical trials in one platform
by: Sebag-Montefiore, D, et al.
Published: (2017)

A Systematic Review of Factors Influencing the Accrual of Patients Into Cancer Trials (Including Reasons Why Clinicians Are Reluctant to Participate in National Multicentre Trials)
by: Ward, L, et al.
Published: (2000)

Analysis of on-trial quality assurance for the SPARC clinical trial using novel peer-review methodology
by: Holyoake, D, et al.
Published: (2018)

Role of adjuvant radiotherapy following neo-adjuvant chemotherapy (NACT) and surgery in oesophageal cancer - a multi-centre retrospective cohort study
by: Teoh, S, et al.
Published: (2016)

Management of depression for people with cancer (SMaRT oncology 1): a randomised trial.
by: Strong, V, et al.
Published: (2008)

An analysis of plan robustness for oesophageal tumours: comparing volumetric modulated arctherapy plans and spot scanning proton planning
by: Warren, S, et al.
Published: (2016)

Oesophageal and gastro-oesophageal junction tumours
by: Bird-Lieberman, E, et al.
Published: (2007)

Definitive chemoradiation in patients with inoperable oesophageal carcinoma.
by: Crosby, T, et al.
Published: (2004)

Normal tissue sparing with respiratory adapted volumetric modulated arc therapy for distal oesophageal and gastro-oesophageal tumours.
by: Hafeez, S, et al.
Published: (2014)

A blinded, randomized controlled trial of neo-adjuvant celecoxib in patients with early prostate cancer.
by: Sooriakumaran, P, et al.
Published: (2006)

Management of depression for people with cancer 4 (SMaRT oncology 1): a randomised trial
by: Strong, V, et al.
Published: (2008)

Patterns of recurrence after definitive chemo-radiotherapy for oesophageal carcinoma
by: Button, MR, et al.
Published: (2007)

A phase-I trial of pre-operative, margin intensive, stereotactic body radiation therapy for pancreatic cancer: the 'SPARC' trial protocol.
by: Holyoake, D, et al.
Published: (2016)

A blinded, randomised controlled trial of neo-adjuvant Celecoxib in patients with localised prostate cancer
by: Sooriakumaran, P, et al.
Published: (2007)

The dose-response of the anal sphincter region--an analysis of data from the MRC RT01 trial.
by: Buettner, F, et al.
Published: (2012)

Oesophagectomy after definitive chemoradiation in patients with locally advanced oesophageal cancer.
by: Borghesi, S, et al.
Published: (2008)

Oesophagectomy after definitive chemoradiation in patients with locally advanced oesophageal cancer.
by: Borghesi, S, et al.
Published: (2008)

Volumetric modulated arc therapy planning for distal oesophageal malignancies.
by: Hawkins, M, et al.
Published: (2012)

PRINCIPLE trial demonstrates scope for in-pandemic improvement in primary care antibiotic stewardship
by: de Lusignan, S, et al.
Published: (2021)

Identifying patients with undetected gastro-oesophageal cancer in primary care: External validation of QCancer® (Gastro-Oesophageal).
by: Collins, G, et al.
Published: (2013)

A prospective comparison of multidisciplinary treatment of oesophageal cancer with curative intent in a UK cancer network.
by: Adams, R, et al.
Published: (2007)

Predicting and understanding outcomes on first-line immunochemotherapy for oesophageal adenocarcinoma: Deep molecular profiling of the LUD2015-005 trial
by: Carroll, T
Published: (2021)

3-STEP TAQMAN RT-PCR: ULTIMATE MESSENGER RNA DETECTION SENSITIVITY FOR CF GENE THERAPY CLINICAL TRIALS
by: McCormick, D, et al.
Published: (2009)

Is the Accrual Anomaly a Global Anomaly?
by: LaFond, Ryan
Published: (2005)

Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trial.
by: Mukherjee, S, et al.
Published: (2013)